Kiora Pharmaceuticals (KPRX) Return on Assets (2016 - 2025)
Kiora Pharmaceuticals' Return on Assets history spans 11 years, with the latest figure at 0.4% for Q4 2025.
- For Q4 2025, Return on Assets fell 50.0% year-over-year to 0.4%; the TTM value through Dec 2025 reached 0.4%, down 50.0%, while the annual FY2025 figure was 0.36%, 50.0% down from the prior year.
- Return on Assets reached 0.4% in Q4 2025 per KPRX's latest filing, down from 0.28% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.14% in Q3 2024 to a low of 1.45% in Q3 2022.
- Average Return on Assets over 5 years is 0.5%, with a median of 0.36% recorded in 2025.
- Peak YoY movement for Return on Assets: crashed -117bps in 2022, then skyrocketed 94bps in 2024.
- A 5-year view of Return on Assets shows it stood at 0.85% in 2021, then tumbled by -72bps to 1.45% in 2022, then soared by 42bps to 0.84% in 2023, then skyrocketed by 111bps to 0.1% in 2024, then tumbled by -517bps to 0.4% in 2025.
- Per Business Quant, the three most recent readings for KPRX's Return on Assets are 0.4% (Q4 2025), 0.28% (Q3 2025), and 0.36% (Q2 2025).